Glucose lowering agents in the Prevention of Cardiovascular events and Mortality in Type II Diabetes.
Topic:
Primary cardiovascular prevention: interventions and outcomes
Speaker:
Doctor V. Menon (Cleveland, US)
Sponsored by Cleveland Clinic
Event:
ESC Congress 2016
Congress Presentation
About the speaker
Doctor Venu Menon
Cleveland Clinic, Cleveland (United States of America)
9
presentations
1
follower
3 more presentations in this session
What is optimal BP? Key differences and controversies among the many guidelines.
Speaker: Doctor L. Cho (Cleveland, US)
Therapeutic Options Targeting Residual CVD Risk: Current Therapies for the Treatment of Dyslipidemia.
Speaker: Professor S. Nicholls (Melbourne, AU)
Pharmacotherapy Options for Obesity and Cardiometabolic Risk: Helpful or Harmful?
Speaker: Professor S. Nissen (Cleveland, US)
Access the full session
Prevention 360: Strategies for Managing Cardiovascular Risk
Speakers:
Doctor V. Menon, Doctor L. Cho, Professor S. Nicholls, Professor S. Nissen
About the event
ESC 365 is supported by
